Psoriasis is a common chronic skin disease mediated by cellular immune mechanisms and characterized by an intense neutrophil cell infiltrate and proliferative activation of epidermal keratinocytes. We have previously described the expression of the inducible nitric oxide synthase (iNOS) in epidermal keratinocytes of psoriatic skin lesions. In this study, the role of iNOS in psoriatic inflammation was explored ex vivo in psoriatic skin biopsies and in vitro in primary cultures of human keratinocytes. Messenger RNA for the iNOS enzyme (iNOS mRNA) was detected by reverse transcriptase polymerase chain reaction in skin biopsies from patients with psoriasis, but not in skin specimens from patients with atopic eczema or from healthy volunteers. As demonstrated by in situ hybridization and immunohistochemistry, expression of iNOS mlLNA and its gene product was localized to the epidermal keratinocytes of psoriatic skin lesions. In situ hybridization further revealed a complete colocalization of mRNA expression for iNOS with interleukin (IL) 8 receptor--specific mRNA either in the basal germinative cell layer or at focal sites of ongoing neutrophil inflammation in suprabasal cell layers. Because psoriatic keratinocytes have previously been shown to express mRNA transcripts for IL-8, it seemed reasonable to hypothesize that iNOS expression could be induced in an autocrine loop by IL-8. This hypothesis was substantiated by our in vitro experiments showing that a combination of IL-8 and interferon ~/ induces the expression of iNOS-specific mRNA and of the functional enzyme in cultured human keratinocytes. These results suggest an important role for iNOS in concert with IL-8 and its receptor early during the formation of psoriatic lesions.
SulTlmary
Psoriasis is a common chronic skin disease mediated by cellular immune mechanisms and characterized by an intense neutrophil cell infiltrate and proliferative activation of epidermal keratinocytes. We have previously described the expression of the inducible nitric oxide synthase (iNOS) in epidermal keratinocytes of psoriatic skin lesions. In this study, the role of iNOS in psoriatic inflammation was explored ex vivo in psoriatic skin biopsies and in vitro in primary cultures of human keratinocytes. Messenger RNA for the iNOS enzyme (iNOS mRNA) was detected by reverse transcriptase polymerase chain reaction in skin biopsies from patients with psoriasis, but not in skin specimens from patients with atopic eczema or from healthy volunteers. As demonstrated by in situ hybridization and immunohistochemistry, expression of iNOS mlLNA and its gene product was localized to the epidermal keratinocytes of psoriatic skin lesions. In situ hybridization further revealed a complete colocalization of mRNA expression for iNOS with interleukin (IL) 8 receptor--specific mRNA either in the basal germinative cell layer or at focal sites of ongoing neutrophil inflammation in suprabasal cell layers. Because psoriatic keratinocytes have previously been shown to express mRNA transcripts for IL-8, it seemed reasonable to hypothesize that iNOS expression could be induced in an autocrine loop by IL-8. This hypothesis was substantiated by our in vitro experiments showing that a combination of IL-8 and interferon ~/ induces the expression of iNOS-specific mRNA and of the functional enzyme in cultured human keratinocytes. These results suggest an important role for iNOS in concert with IL-8 and its receptor early during the formation of psoriatic lesions. p psoriasis is a genetically determined disease of the skin characterized by two biological hallmarks. First, there is profound epidermal hyperprohferation related to accelerated and incomplete differentiation. Second, there is marked inflammation of both epidermis and dermis with an increased recruitment of cycling T lymphocytes and formation of neutrophil microabscesses (1, 2) . Many pathologic features of psoriasis can be attributed to alterations in the growth and maturation of epidermal keratinocytes (2). Moreover, convincing evidence has been accumulated indicating that epidermal keratinocytes are also crucial to cutaneous inflammatory and immune responses in psoriasis by elaborating various cytokines, adhesion molecules, and chemotactic factors, notably IL-8 (3, 4) . The consequences are activation of dermal microvascular endothelial cells and selective accumulation of specific mononuclear cells within focal skin areas (4) .
Despite recent advances in the understanding of the skin immune system, the regulatory and effector mechanisms underlying epidermal and immunological activation in psoriasis remain incompletely understood. In a previous report we demonstrated expression of the inducible nitric oxide synthase (iNOS) by epidermal keratinocytes and its association with psoriatic skin lesions (5) . iNOS is a P-450-type cytoplasmic hemeprotein that catalyzes the conversion of L-arginine to L-citmlline and nitric oxide (NO) (6, 7) . NO, in addition to its role as a cellular messenger at low concentrations, has been shown to play a decisive role in inflammatory and autoimmune tissue injury because of its cytotoxic and immunoregulatory properties when synthesized at high concentrations (7) (8) (9) . The inducible isoform of NOS is able to produce large amounts of NO and can be expressed in a number of mammalian cells after challenge with proinflammatory cytokines, such as IFN-~/, TNF-ot, and IL-I[~ (10, 11) . It seems reasonable, therefore, to suggest that iNOS expression in epidermal keratinocytes of psoriasis might be induced by cytokines present in their immediate environment. In fact, a complex pattern of cytokine expression has been demonstrated in psoriatic lesions, including IFN-~/, TNF-0~, I1-113, IL-2, and IL-6, each of which potentially contributes to epidermal activation (2, 4) . Most recently, it became evident that IL-8 appears to be pivotal in the formation of psoriatic lesions, responsible for prominent leukocytic infiltration as well as keratinocyte hyperproliferation (12, 13) . In epidermal keratinocytes of psoriatic skin lesions we demonstrated increased expression of IL-8 and its receptor (IL-8PQ (13) . Furthermore, we identified the epidermal IL-8I( as the molecular target for the immunomodulatory antipsoriatic drug FK 506 (tacrolimus) as well as other antipsoriatic agents (14, 15) .
It is currently well established that the cytokine-inducible NOS is involved in diverse physiologic and pathophysiologic processes, including host immune defense, immunoregulation, and tissue destruction in autoimmune diseases (16, 17) . Investigations on its role and expression in common skin diseases, however, are lacking. This report demonstrates that mRNA transcripts of iNOS, expressed by epidermal keratinocytes in psoriatic skin lesions, are colocalized with mI(NA transcripts of the epidermal IL-8P,. Moreover, we here show for the first time that IL-8 is a potent costimulatory inducer for iNOS expression in cultured human keratinocytes, providing a mechanism to link induction of iNOS with the characteristic neutrophil inflammation in psoriasis.
Materials and Methods

Selection and Preparation of Skin Sections
Fresh keratoma biopsies were taken from lesional and nonlesional skin of 15 patients with untreated, longstanding psoriasis and, for control purposes, from 10 pauents with atoplc eczema and 10 healthy volunteers. Skin biopsies were flash frozen in liquid nitrogen and used for either reverse transcnptase (R.T) PCR, in SltU hybridization, or redirect immunohistochemistry.
Cell Stimulation and Culture
Cell Culture Reagents. Complete medium consisted of Keratinocyte-SFM (Gibco Laboratories, Grand Island, NY) supplemented with 2.5 ng/ml epidermal growth factor, 25 ~g/ml bovine pituitary extract, 70 U/ml penicillin, and 70 b~g/ml streptomycin. Homogeneous rlL-8 was obtained from R.&D Systems (Abingdon, UK). Recombinant human IFN-',/, TNF-o~, and IL-113 were purchased from HBT (Leiden, Netherlands).
Cell Purification. Primary epidermal keratinocytes were prepared from reduction mammoplasty specimens essentially as described (3). Cells were grown in vitro on plastic substrates under standard culture conditions. Primary cultures consisted of pure epidermal keratmocytes as also demonstrated by antlcytokeratln immunocytochermstry.
Cell Stimulation. For stimulation of 1NOS expression, pnmary human keratinocytes were cultured in Keratinocyte-SFM without epidermal growth factor and bovine pituitary extract. Confluent monolayers were incubated for 24 h in the presence or absence oflL-8, IFN-~/, TNF-o~, and/or 1L-113. The capacity of these cytokines to induce iNOS expression was evaluated using R.T-PCR amplification, in situ hybridization, redirect lmmunocytochernistry, and a colorimetnc nitrite assay to quantify nitrite accumulation in the cell culture medium. Experiments were performed with cells m either their second or third passage in vitro.
IL-8 and Inducible Nitric
R T-PCR Analysis
Freshly harvested epidermal cells or tissues were flash frozen m hquid nitrogen. Total RNA extraction was performed using guanichnium tl-nocyanate as described (13) . F~rst strand cDNA was prepared from 1 ~g of RNA using Avaan moloney leukemia wrus reverse tramcriptase (Boehringer Mannheim, Marmheim, Germany) under the conditions suggested by the supplier. After reverse transcription, amplification was carried out by PCR using Taq polymerase (Gibco Laboratories) with 15 mM MgCh. PCR was performed with primers specific for iNOS (5'-ATGCCAGAT-GGCAGCATCAGA-3' and 5'-TTTCCAGGCCCATTCTCC-TGC-3'), yielding a 394-bp product; and for glyceraldehyde-3-phosphate-dehydrogenase (G3DPH; 5'-ACAGTCCATGCCAT-CACTGCC-3' and 5'-GCCTGCTTCACCACCTTCTTG-3') to yield a 228-bp product. Cycle times were 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C for 35 cycles. 20% of the iNOS reaction was combined with 5% of the G3PDH reaction and analyzed tbr the presence or absence of the 1NOS species by electrophoresxs on a 2% agarose gel.
In Situ Hybridization Studies
Preparation Hybridization Procedure. The protocol described by Leltch et al.
(18) was used with minor alterations. In brief, 7-~m cryostat sections or cultured human keratinocytes were hybridized with dlgoxlgenm-labeled antlsense and sense nboprobes for iNOS or IL-8R.. After posthybridizanon high-stringency washing procedures, slides were incubated with an alkaline phophatase-labeled antldigoragenin Ab (Boehringer Mannheim). Visualization of the probe hybridization side was performed using 5-bromo-4-chloro-3-indolyl phosphate tolmdine and mtroblue tetrazolium salt as chromogemc enzyme substrates (Boehnnger Mannhexm). No positive hybndization signals were observed in any specimens treated with the sense riboprobes.
Immunohistochemical Analysis Of iNOS Protein
The immunohistochemical procedures followed methods described previously (5) and were performed on 7-p~m frozen sections of keratoma biopsies or cultured human keratinocytes. A mouse mAb to macrophage iNOS (Transduction Laboratories, Lexington, KY) was used to assess expression of 1NOS protein.
For negative controls, the first mAb was either omltted or replaced by an irrelevant isotype-matched reagent. These experiments consistently yielded negative results. Because it has recently been observed that the iNOS Ab may cross-react with the constitutive NOS proteins (19) , serial sections were also stained with a polyclonal anti-neuronal antiserum and a monoclonal anti-endothelial Ab (both from Transductlon Laboratories) to test the specificity of the iNOS mAb. None of these latter Abs resulted in staining of epidermal kerafinocytes.
Oxide Synthase in Psoriasis and Keratinocytes 1NOS mRNA is not expressed by epidermal keratinocytes oflesmnal skin from patxents with atopm eczema nor (C) in skin specimens from healthy volunteers.
Nitrite Assay
NO synthesis in primary cultures of human keratmocytes was determined by measuring the accumulation of nitrite (NO2-), a stable end product of NO metabolism, using a modified Griess reaction as described earher (19) .
Results and Discussion
The specific expression of iNOS mRNA ex vivo was determined in keratoma biopsies from patients with psoriasis or atopic eczema and from healthy volunteers using tLT-PCP,, amplification, iNOS mR.NA transcripts were demonstrated in all keratoma biopsies (n = 15) from lesional psoriatic skin and in 5 out of 15 of the corresponding nonlesional skin biopsies (Fig. 1 A) . The strong signal for iNOS mR.NA observed in these nonlesional skin specimens appears to be due to preclinical inflammatory skin alterations. In contrast, all keratoma biopsies of atopic eczema (n = 10) were devoid of any iNOS message, as were all skin specimens from healthy volunteers (n = 10) (Fig. 1,  Band C) .
To determine the localization of iNOS mRNA transcripts in psoriatic skin lesions, in situ hybridization was performed using cryostat sections of the same biopsies (n = 5 for each of the three groups). Specific signals for iNOS mRNA were detected in keratinocytes of the epidermal compartment of psoriatic skin biopsies showing two essentially different localization patterns. In two out of five biopsies, keratinocytes of the highly proliferative basal epidermal layer yielded a strong and specific signal for iNOS mRNA located in a bandlike pattern, where the hybridization signal was preferentially observed at the tips of the fete ridges (Fig. 2 A) . In three out of five lesional skin specimens, however, epidermal keratinocytes showed a focal pattern of expression in the suprabasal cell layers, often closely associated with focal clusters of infiltrating inflammatory cells of neutrophil morphology (Fig. 2 C) . In two out of five nonlesionat psoriatic skin specimens, abundant signals were detected in the basal epidermal layer (Fig. 2 E) , again suggesting a potential role of iNOS in the early phase of tissue inflammation m psoriasis.
hnmunohistochemical staining of psoriatic skin specimens (n = 10) also localized the iNOS to the epidermal keratinocytes. Identical to in situ hybridization patterns, keratmocytes that stained for iNOS were rather localized in the basal epidermal layer (Fig. 2 F) of lesional or nonlesional skin, respectively, or were focally clustered at sites of ongoing neutrophil inflammation in suprabasal cell layers (Fig. 2 G) . In contrast, no epidermal iNOS mlLNA or protein was detected in any of the skin specimens from patients with atopic eczema nor from healthy volunteers (data not shown).
IL-8 is known to play a critical role in neutrophil chemotaxis (12, 13) , and mI<NA transcripts for IL-8 or IL-8R and IL-8 immunoreactivity were found either focally clustered in suprabasal keratinocytes associated with infiltrating neutrophils or confined to basal epidermal keratinocytes of psoriatic skin lesions (12, 20) . Because we have shown increased expression of mRNA transcripts for IL-8 and its receptor in epidermal keratinocytes of psoriasis using R.T-PCP,. amplification (13), we now analyzed the localization of IL-8R-expressing cells in serial sections of the same psoriatic skin specimens using in situ hybridization. In complete accordance with the expression pattern observed for iNOS gene expression, we found IL-8R mRNA transcripts to be colocalized with iNOS mRNA transcripts either in the basal epidermal compartment or in the suprabasal cell layers at sites of ongoing neutrophil inflammation (Fig. 2, B and D) . The simultaneous expression of both iNOS and IL-8R gene in psoriatic epidermal keratinocytes suggests a paracrine and/or autocrine pathway involved in Figure 2 . Colocalizatlon of 1NOS and IL-8tk in skin specimens of psoriasis by m sxtu hybndazation (A-E) and unmunobastochemistry (F and G). For in SltU hybridization experiments, blue staining of the cytoplasm is indicative of cells containing the respective transcripts. In lmmunolabehng, brown signals are obtained with blue nuclei due to hematoxyhn counterstaining. (A) In lesional psonanc skin, the epidermal keratmocytes of the highly proliferative basal cell layer yielded a strong and specific signal for iNOS in a bandlike hybridization pattern. (B) The locahzanon of mP, NA transcnpts for IL-8R completely corresponds to the dastnbutmn of mRNA transcripts for iNOS shown an A (C) In a minority oflesmnal psonatac skin biopsies, the cells expressing 1NOS rnRNA cluster m suprabasal cell layers. (D) In these specimens, IL-8R-specific mRNA as coexpressed in the suprabasal kerannocytes of psonanc epidermis. (E) Strong and specific signals for aNOS mtLNA an a bandllke pattern were observed an a minority of nonleslonal skin biopsies obtained from psoriatic pauents. Control studles performed with sense nboprobes for 1NOS or IL-8R were uniformly negative. (F and G) Immunohlstochemlcal localization of 1NOS protern m the epidermis oflesional psoriatic skin. Note the prominent staining in the basal epidermal cell layer (F) or at sites of ongoing neutrophil inflammation (G). Senal secuons were also stained for ecNOS or ncNOS, which dad not label keratlnocytes.
local l e u k o c y t e r e c r u i t m e n t as w e l l as k e r a t i n o c y t e activation.
Earlier studies h a v e s h o w n that t h e i N O S g e n e can b e s t i m u l a t e d in a n u m b e r o f m a m m a l i a n cells b y p r o i n f l a mm a t o r y c y t o k i n e s , n o t a b l y I F N -y , T N F -o t , a n d IL-113 (10, 11) . A direct i n t e r a c t i o n , h o w e v e r , b e t w e e n i N O S g e n e e x p r e s s i o n a n d t h e c y t o k i n e s k n o w n to b e i n v o l v e d in p s oriatic i n f l a m m a t i o n (2, 20) has n o t y e t b e e n d e m o n s t r a t e d for p r i m a r y h u m a n k e r a t i n o c y t e s . T o e x a m i n e w h e t h e r e p i d e r m a l k e r a t i n o c y t e s c a n b e i n 
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Cultured human keratinocytes Figure 5 . N~tnte production by cytokme-challenged human keratinocyte cultures. Primary human keratlnocytes were cultured m the presence or absence of 10 nM IL-8, 1,000 U/ml IFN-y, 1,000 U/ml TNF-0t, and 1,000 U/ml I1-113. After 24 h ofincubanon, mtrlte production in the culture me&a was deternnned spectrophotometncally by a modified Gness reacnon, and the presented results are the mean +_. SD of three experiments performed in duplicate.
by signals present in a psoriatic microenvironment, we treated cultured normal human keratinocytes with IL-8, either alone or in combination with IFN-3,, TNF-ot, or IL-113. Whereas none of these cytokines was active when added as single components, IL-8 (10 nM) in combination with IFN-y (1,000 U/ml) resulted in iNOS mlLNA expression in human keratinocytes as detected by ILT-PCP,. (Fig. 3 , lanes A-D and F) and in situ hybridization (Fig. 4 B) . The translation into protein was verified by immunocytochemistry (data not shown). The combination of TNF-ci with IL-113 was also found to be effective in inducing iNOS mP,.NA (Fig. 3, lane G) or protein, whereas IFN-y in combination with TNF-0t or IL-113 (Fig. 3 , lane E) proved to be ineffective. Priming of keratinocytes with IFN-y for 24 h followed by stimulation with IL-8, TNF-0t, or IL-113 also failed to induce iNOS expression in cultured human keratinocytes (data not shown). Neither iNOS-specific mRNA ( Fig. 3 " i', and Fig. 4 A) nor its gene product were detected in unchallenged keratmocytes. Nitrite accumulation in the cell culture media was found to exactly parallel the response profiles seen with iNOS mlLNA and protein detection methods (Fig. 5) . Increased nitrite formation was not detected in the presence of 0.5 mM/Va-monomethylr-arginine, These findings introduce iNOS as a molecular signal present in the inflammatory response of epidermal keratinocytes and extend our previous efforts to unravel the molecular pathophysiology of inflammation in psoriasis. Moreover, our studies establish a unique profile of cytokine responsiveness in human keratinocytes, because iNOS expression could only be induced by synergistic combinations of IL-8 plus IFN-~/or TNF-ot plus IL-1[3. This profile for NOS induction clearly distinguishes human keratinocytes from other cells and tissues in which inducibility is also conferred by single activators or other cytokine combinations. Thus, expression of iNOS in human hepatocytes--of epithelial cell origin also--is known to be controlled at the level of transcription by IL-113 alone or in combination with IFN-',/(8), which is ineffective m keratinocytes. The observation of iNOS expression in psoriatic but not in atopic skin specimens demonstrates a key role for the local cytokine profile an the regulation of iNOS expression m vivo.
Our contention that iNOS is involved in the pathogenesis of psoriasis is further supported by the antiinflammatory effects of retinoids in the treatment of psoriasis, which have been shown to inhibit iNOS gene transcription (21) .
In this study we provide the first experimental evidence that IL-8, which is a potent chemotactic agent for both neutrophils and T lymphocytes at nanomolar concentrations (14) , is of central importance for keratinocyte iNOS gene expression. The fact that IL-8 induces iNOS expression only in combination with T lymphocyte-derived IFN-~/ corresponds to the finding that T lymphocytes involved in psoriasis belong to the Thl subset producing the proinflammatory cytokines IFN-y and IL-2 (22) . In summary, our results support the idea that the role of IL-8 and its receptor in psoriasis is not limited to proinflammatory and neutrophil-attracting functions, but that IL-8 in combination with IFN-'y also acts as an autocrine or paracrine immunomodulator by eliciting the NO pathway. A previous report showed IL-8-mediated downregtflation of iNOS expression in neutrophils (23) , which may be an indication of different gene expression regulations in different cell types. We also found the combinanon of TNF-o~ and IL-1[3 as a potent inducer of iNOS expression. Because TNF-ci and IL-113 have been shown to enhance IL-8 release from human keratinocytes (20) , iNOS expression in keratinocytes may result via a common IL-8 pathway.
It is tempting to further speculate that iNOS expression in psoriatac lesions is involved in the alterations of epidermal proliferation and differentiation, because in neuronal cells the induction of iNOS is an important step in the arrest of cell proliferation and initiates the switch to terminal differentiation (24) . Moreover, NO-mediated activation of the soluble heme-containing guanylate cyclase is known to result in increased intracellular levels of cGMP, a known regulator of cell growth and differentiation. Indeed, increased cGMP levels are found in psoriatic skin lesions and therefore may be causally related to iNOS gene expression (25).
Further eluctdation of the molecular signals involved in the regulatory and effector mechanisms of iNOS expression in epidermal keratinocytes may give insights into the pathogenesis of psoriasis. Modulation of iNOS expression could provide a therapeutic aim in psoriasis and other immune-mediated skin diseases.
